References
- Hester JB, Rudzik AD, Kamdar BV. 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity. J Med Chem. 1971;14(11):1078–1081.
- Carpenter JE, Murray BP, Dunkley C, et al. Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017. Clin Toxicol (Phila). 2019;57(4):282–286.
- Ghazi M, Mohmand M. Co-occurring addiction of synthetic benzodiazepine clonazolam and propylhexedrine presenting as acute brief psychosis. J Addict Med Ther. 2017;5(2):1037.
- Moosmann B, Auwärter V. Designer benzodiazepines: another class of new psychoactive substances. In: Handbook of experimental pharmacology. 9th Ed. Vol. 252, 2018; pp. 383–410. Cham, Switzerland: Springer Nature.
- Bäckberg M, Pettersson Bergstrand M, Beck O, et al. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project. Clin Toxicol (Phila). 2019;57(3):203–212.
- Huppertz LM, Bisel P, Westphal F, et al. Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites. Forensic Toxicol. 2015;33(2):388–389.
- Cornett EM, Novitch MB, Brunk AJ, et al. New benzodiazepines for sedation. Best Pract Res Clin Anaesthesiol. 2018;32(2):149–164.
- Meyer MR, Pettersson Bergstrand MP, Helander A, et al. Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Anal Bioanal Chem. 2016;408(13):3571–3591.
- Pettersson Bergstrand M, Helander A, Beck O. Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine . J Chromatogr B Anal Technol Biomed Life Sci. 2016;1035:104–110.
- Pettersson Bergstrand M, Helander A, Hansson T, et al. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. Drug Test Anal. 2017;9(4):640–645.